10-K: Churchill Capital IX Faces Liquidity Doubts Amid PlusAI Merger

Churchill Capital Corp IX, a SPAC, reported a net income of $8.56 million for 2025 but faces substantial doubt about its ability to continue as a going concern while pursuing its merger with PlusAI.

Summary

• Churchill Capital Corp IX (CCIX) is a blank check company formed to complete a business combination, with its efforts currently focused on a merger with Plus Automation, Inc. (PlusAI).
• The company reported a net income of $8,556,703 for the fiscal year ended December 31, 2025, compared to $8,791,874 in 2024.
• Interest income from marketable securities and cash held in the Trust Account was $12,494,752 in 2025, up from $9,622,647 in 2024.
• General and administrative costs significantly increased to $3,938,049 in 2025 from $830,773 in 2024.
• As of December 31, 2025, the company had $307,617,399 in marketable securities and cash in its Trust Account, with a redemption price of approximately $10.70 per Public Share.
• The extraordinary general meeting (EGM) to approve the PlusAI Business Combination has been rescheduled from February 3, 2026, to February 11, 2026, to allow for further shareholder engagement.
• The PlusAI Business Combination values PlusAI at a pre-money equity value of $1,200,000,000, subject to closing adjustments.
• An earnout consideration of up to 15,000,000 additional shares of SPAC Common Stock is possible over a five-year period, contingent on specific price targets ($12.00 and $14.00 VWAP).
• The closing condition requiring $100 million in Available Closing SPAC Cash for the PlusAI merger was removed via an amendment on September 18, 2025.
• The company has a deadline of August 6, 2026, to consummate its initial Business Combination, after which it would liquidate and redeem Public Shares.
• Management has determined there is substantial doubt about the company's ability to continue as a going concern due to liquidity needs and the mandatory liquidation deadline if a business combination is not completed.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing with cautious optimism. While the PlusAI merger progresses and a key closing condition was removed, the explicit 'going concern' warning and the EGM postponement introduce notable uncertainties, balancing the positive aspects of the potential transaction.

Positives

• The company generated significant interest income of $12,494,752 from its Trust Account in 2025, indicating effective management of parked capital.
• The proposed PlusAI Business Combination has a substantial pre-money equity valuation of $1,200,000,000, suggesting a potentially valuable target.
• The removal of the $100 million Minimum Cash Condition for the PlusAI merger simplifies a key closing hurdle, potentially increasing the likelihood of deal completion.
• The company has a clear strategy to leverage its management team's and M. Klein and Company's experience and network for sourcing and executing business combinations.

Negatives

• The company has a working capital deficit of $11,266 as of December 31, 2025, indicating insufficient liquidity for ongoing operations outside the Trust Account.
• General and administrative costs increased significantly from $830,773 in 2024 to $3,938,049 in 2025, impacting net income.
• The auditor's report explicitly states 'substantial doubt about our ability to continue as a going concern' due to liquidity needs and the mandatory liquidation deadline.
• The postponement of the EGM for the PlusAI Business Combination could signal challenges in securing shareholder approval or other unforeseen issues.
• The company's reliance on its Sponsor for Working Capital Loans (up to $1,500,000) highlights its limited independent financial flexibility.

Risks

• Inability to complete the initial Business Combination, including the PlusAI Business Combination, within the Combination Period (by August 6, 2026), leading to liquidation and redemption of Public Shares at or below the Redemption Price.
• Potential for increased competition for attractive target businesses, which could raise acquisition costs or prevent the completion of a Business Combination.
• Issuance of Ordinary Shares to investors in connection with the initial Business Combination at a price less than the prevailing market price, leading to dilution.
• Public Shareholders may not have an opportunity to vote on the proposed initial Business Combination, or their vote may be outweighed by Founder Shares.
• Resources could be wasted on researching Business Combination targets that are not completed, adversely affecting subsequent attempts.
• Fluctuations in inflation and interest rates, military conflicts, and other disruptions could make it more difficult to consummate a Business Combination.
• Changes in laws or regulations, including the U.S. federal 1% excise tax on stock repurchases, may adversely affect the business.
• Insufficient funds from interest income on the Trust Account balance for Permitted Withdrawals to operate the business prior to the Business Combination.
• Adverse developments in the financial services industry, including liquidity concerns, could impact Business Combination prospects.
• Cyber incidents or attacks could result in information theft, data corruption, operational disruption, and financial loss.
• Risk of being deemed an investment company under the Investment Company Act, leading to burdensome compliance requirements and restricted activities.
• The ability of Public Shareholders to redeem a large number of shares and the payment of the Deferred Fee may hinder the completion of the most desirable Business Combination or optimize capital structure, and may dilute Public Shareholders' investment.
• The requirement to complete the Business Combination within the Combination Period may give target businesses leverage in negotiations and limit due diligence time.
• Conflicts of interest may arise due to the Sponsor, officers, and directors having other business affiliations and potentially profiting substantially even if Public Shareholders experience losses.
• The value of Founder Shares is likely to be substantially higher than their nominal purchase price, even if Public Shares decline.
• Nasdaq may delist the company's securities if it fails to meet listing requirements, including the 36-month requirement to complete a Business Combination.
• Shareholders may face difficulties protecting their interests due to the company's Cayman Islands incorporation and potential for directors/officers to reside outside the U.S. post-merger.
• The company is an emerging growth company and smaller reporting company, which may make its securities less attractive to some investors due to reduced disclosure requirements.
• Substantial doubt about the company's ability to continue as a going concern through approximately one year from the financial statement issuance date.

Future Outlook

The company intends to complete the PlusAI Business Combination before the August 6, 2026 deadline. It may seek additional financing if needed for the transaction or if a significant number of Public Shares are redeemed. The post-combination company, PlusAI Holdings, Inc., is expected to be listed on Nasdaq, and an earnout consideration of up to 15,000,000 shares is planned for eligible PlusAI security holders over five years, contingent on stock price performance.

Management Comments

• "We believe that our Management Team and M. Klein and Company... are well positioned to identify and execute attractive Business Combination opportunities."
• "Our objectives are to generate attractive returns for shareholders and enhance value through selecting a high-quality target at an attractive valuation, negotiating favorable acquisition terms for our shareholders and improving operational performance of the acquired company."
• "Management plans to consummate an initial Business Combination prior to the end of the Combination Period."
• "Our Board of Directors decided to postpone the EGM in order to allow additional time for our Company to engage with our shareholders, including following the announcement by PlusAI regarding its expanded partnership with TRATON Group."

Industry Context

StockSavvy.ai notes that Churchill Capital Corp IX operates within the highly competitive SPAC market, which has seen increased scrutiny and competition for attractive targets. The proposed merger with PlusAI, an AI-focused company, aligns with broader industry trends towards technology and automation. The postponement of the EGM, while potentially concerning, is not uncommon in complex SPAC transactions, especially when allowing for further shareholder engagement and incorporating new developments like PlusAI's partnership with TRATON Group. The explicit 'going concern' warning, however, highlights the inherent risks and time pressures unique to SPACs if a deal is not finalized.

Comparison to Industry Standards

• The SPAC's structure, including the 80% Test for target valuation and the redemption rights for public shareholders, is standard for the industry.
• The $10.00 per unit IPO price and $11.50 warrant exercise price are typical for SPACs.
• The deferred underwriting fee of $10,062,500 (3.5% of gross proceeds) is a common incentive structure for underwriters in SPAC transactions.
• The pre-money equity valuation of PlusAI at $1.2 billion is a significant size for a SPAC target, indicating a potentially substantial transaction compared to many smaller SPAC deals.
• The earnout structure with price targets of $12.00 and $14.00 VWAP is a common mechanism in SPAC mergers to align post-closing incentives and reward long-term value creation, similar to those seen in other technology-focused SPAC combinations.

Corporate Governance

Related Party Transactions

• Sponsor (Churchill Sponsor IX LLC) acquired 7,187,500 Founder Shares for $25,000.
• Sponsor purchased 725,000 Private Placement Units for $7,250,000.
• An affiliate of the Sponsor is reimbursed $30,000 per month for office space, utilities, and administrative support under the Administrative Support Agreement.
• The IPO Promissory Note, under which the Sponsor loaned up to $600,000 to the company, was fully repaid by May 8, 2024.
• The WCL Promissory Note was issued to the Sponsor on December 2, 2025, for up to $1,500,000 in Working Capital Loans, with $250,000 borrowed on January 13, 2026. These loans are convertible into WCL Conversion Units.
• The company has agreed to indemnify its Sponsor and its members, managers, and affiliates for certain claims, excluding those from the Trust Account.
• The Sponsor, officers, and directors are reimbursed for out-of-pocket expenses incurred in connection with identifying and completing a Business Combination, with no cap or ceiling on reimbursement.

Stakeholder Impact

• Shareholders face potential dilution from the issuance of new shares in the Business Combination and the conversion of Founder Shares and WCL Promissory Notes.
• Public Shareholders have redemption rights, allowing them to exit their investment at approximately $10.70 per share if they do not approve the Business Combination or if the SPAC liquidates.
• The Sponsor and management team have significant incentives to complete a Business Combination, as their Founder Shares would become worthless upon liquidation.
• The proposed merger with PlusAI could provide a liquidity event for PlusAI's existing equity holders and offer a path to public market access.
• The postponement of the EGM may cause uncertainty for all stakeholders regarding the timing and ultimate success of the PlusAI Business Combination.

Next Steps

• Hold the extraordinary general meeting (EGM) on February 11, 2026, to seek shareholder approval for the PlusAI Business Combination.
• Complete the domestication to a Delaware corporation (PlusAI Holdings, Inc.) at least one day prior to the closing of the Mergers.
• Consummate the PlusAI Business Combination following shareholder approvals and satisfaction or waiver of other closing conditions.
• File a registration statement for the resale of certain securities held by Reg Rights Holders within 15 business days after the Closing.
• Continue efforts to identify and evaluate alternative Business Combination opportunities if the PlusAI Business Combination is not consummated by August 6, 2026.

Key Dates

Recommendation

The company is a SPAC with a pending business combination, which inherently carries significant risk and potential for volatility. While the proposed merger with PlusAI has a substantial valuation and the removal of a key cash condition is positive, the 'going concern' warning and the EGM postponement introduce uncertainty. Investors should hold existing positions and monitor the outcome of the EGM and the progress of the PlusAI Business Combination, as the success or failure of this merger will be the primary driver of future share price performance. A 'buy' or 'sell' recommendation would be premature given the binary nature of SPACs and the pending shareholder vote.

Keywords

SPAC, Churchill Capital Corp IX, PlusAI, Business Combination, Merger, 10-K, SEC Filing, Financial Report, Going Concern, Special Purpose Acquisition Company, Corporate Governance, Risk Factors, Trust Account, Warrants, Redemption, Cayman Islands, Delaware Domestication, Earnout, TRATON Group